Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Acinar Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00489515
What this trial is testing

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

Who this might be right for
Colorectal CancerGallbladder CancerGastric Cancer+2 more
Wake Forest University Health Sciences 115
Not applicableUnknownNCT02209415
What this trial is testing

EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer

Who this might be right for
Esophageal CancerStomach CancerPancreatic Cancer
Michael Bau Mortensen 182
Testing effectiveness (Phase 2)Study completedNCT00052689
What this trial is testing

Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasStage IV Pancreatic Cancer
National Cancer Institute (NCI) 88
Large-scale testing (Phase 3)Ended earlyNCT02356640
What this trial is testing

EUS-guided CGN for Inoperable Cancer

Who this might be right for
Intractable Abdominal Pain Secondary to Inoperable Malignancy
Chinese University of Hong Kong 3
Not applicableActive Not RecruitingNCT06001268
What this trial is testing

Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 80
Early research (Phase 1)Study completedNCT01204476
What this trial is testing

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Who this might be right for
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)WithdrawnNCT05415917
What this trial is testing

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

Who this might be right for
Pancreatic Cancer
Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Active Not RecruitingNCT05604560
What this trial is testing

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Lei Zheng 25
Not applicableUnknownNCT03500068
What this trial is testing

Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.

Who this might be right for
Carcinoma, Pancreatic Ductal
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Early research (Phase 1)Study completedNCT04080024
What this trial is testing

A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer

Who this might be right for
Breast CancerPancreas Cancer
Spago Nanomedical AB 14
Not applicableStudy completedNCT01846520
What this trial is testing

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Who this might be right for
Healthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more
City of Hope Medical Center 200
Testing effectiveness (Phase 2)UnknownNCT05064618
What this trial is testing

Investigator-initiated Clinical Trial of MIKE-1

Who this might be right for
Pancreatic Cancer
Nagoya University 55
Testing effectiveness (Phase 2)Study completedNCT00711997
What this trial is testing

Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Anchiano Therapeutics Israel Ltd. 9
Large-scale testing (Phase 3)Study completedNCT00994110
What this trial is testing

Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 439
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04666688
What this trial is testing

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorPancreatic Cancer+3 more
PureTech 44
Not applicableActive Not RecruitingNCT07271823
What this trial is testing

Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Zhejiang Cancer Hospital 100
Not applicableStudy completedNCT04128332
What this trial is testing

Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer

Who this might be right for
Cancer of Pancreas
CCTU- Cancer Theme 10
Early research (Phase 1)UnknownNCT05369312
What this trial is testing

Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients

Who this might be right for
Solid TumorNon-small Cell Lung CancerPancreatic Cancer+1 more
Betta Pharmaceuticals Co., Ltd. 230
Not applicableLooking for participantsNCT06494514
What this trial is testing

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Du Juan 40
Next Page